{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:18:16Z","timestamp":1788430696353,"version":"build-2803163510"},"reference-count":25,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Postbariatric hypoglycemia (PBH) represents a challenging complication of bariatric surgery. This case series describes 3 patients with PBH following Roux-en-Y gastric bypass who were treated with tirzepatide, a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA). All patients presented with symptomatic hypoglycemia characterized by episodes of diaphoresis, visual disturbances, confusion, and documented low blood glucose levels occurring postprandially. Conventional management strategies, including dietary modifications, acarbose, and other pharmacotherapies, were either partially effective or limited by side effects. Initiation of tirzepatide led to increased time in range, reduced number and severity of hypoglycemic episodes, and decreased glucose variability. This report suggests that GLP-1 and GIP RA can be a promising adjunct in managing PBH; however, further studies to confirm their efficacy and establish optimal dosing strategies are needed.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag216","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:11:06Z","timestamp":1786101066000},"source":"Crossref","is-referenced-by-count":0,"title":["Tirzepatide for treatment of postbariatric hypoglycemia after Roux-en-Y gastric bypass: a report of 3 cases"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7064-1873","authenticated-orcid":false,"given":"Jovan","family":"Milosavljevic","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Montefiore Medical Center , Bronx, NY 10467, USA"},{"name":"Albert Einstein College of Medicine Department of Medicine, , Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Meyer","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine Department of Medicine, , Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A","family":"Levine","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Montefiore Medical Center , Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saachi","family":"Sachdev","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Montefiore Medical Center , Bronx, NY 10467, USA"},{"name":"Albert Einstein College of Medicine Department of Medicine, , Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"4","key":"2026090305475653100_luag216-B1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s11695-024-07118-3","article-title":"IFSO worldwide survey 2020-2021: current trends for bariatric and metabolic procedures","volume":"34","author":"Angrisani","year":"2024","journal-title":"OBES SURG"},{"issue":"1","key":"2026090305475653100_luag216-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.orcp.2015.07.003","article-title":"Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery","volume":"10","author":"Malik","year":"2016","journal-title":"Obes Res Clin Pract"},{"issue":"11","key":"2026090305475653100_luag216-B3","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-010-1798-5","article-title":"Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden","volume":"53","author":"Marsk","year":"2010","journal-title":"Diabetologia"},{"issue":"7","key":"2026090305475653100_luag216-B4","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s11695-014-1260-8","article-title":"Hypoglycemia after Roux-en-Y gastric bypass: the BOLD experience","volume":"24","author":"Sarwar","year":"2014","journal-title":"OBES SURG"},{"issue":"6","key":"2026090305475653100_luag216-B5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.soard.2018.01.028","article-title":"The incidence and risk factors associated with developing symptoms of hypoglycemia after bariatric surgery","volume":"14","author":"Lee","year":"2018","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"2026090305475653100_luag216-B6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"2026090305475653100_luag216-B7","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1152\/ajpendo.00073.2012","article-title":"Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance","volume":"303","author":"J\u00f8rgensen","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2026090305475653100_luag216-B8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2014.01.038","article-title":"Hypoglycemia after gastric bypass: the dark side of GLP-1","volume":"146","author":"Patti","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"2026090305475653100_luag216-B9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1530\/EJE-17-0446","article-title":"Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass","volume":"177","author":"Tharakan","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026090305475653100_luag216-B10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2337\/db22-0568","article-title":"The importance of endogenously secreted GLP-1 and GIP for postprandial glucose tolerance and \u03b2-cell function after Roux-en-Y gastric bypass and sleeve gastrectomy surgery","volume":"72","author":"Hinds\u00f8","year":"2022","journal-title":"Diabetes"},{"issue":"8","key":"2026090305475653100_luag216-B11","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1210\/jc.2018-00528","article-title":"Hypoglycemia after gastric bypass surgery: current concepts and controversies","volume":"103","author":"Salehi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026090305475653100_luag216-B12","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/dom.13796","article-title":"Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide","volume":"21","author":"\u00d8hrstr\u00f8m","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2026090305475653100_luag216-B13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1530\/EJE-13-0504","article-title":"GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication?","volume":"169","author":"Abrahamsson","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026090305475653100_luag216-B14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/oby.23600","article-title":"The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review","volume":"31","author":"Llewellyn","year":"2023","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"2026090305475653100_luag216-B15","article-title":"Tirzepatide improves early dumping syndrome and glucose nadir in postbariatric hypoglycemia after sleeve gastrectomy","volume":"2","author":"Stortz","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"5","key":"2026090305475653100_luag216-B16","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.soard.2017.01.025","article-title":"Medical nutrition therapy for post-bariatric hypoglycemia: practical insights","volume":"13","author":"Suhl","year":"2017","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"2026090305475653100_luag216-B17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2337\/diacare.3.1.58","article-title":"Characteristics of glycemic stability","volume":"3","author":"Service","year":"1980","journal-title":"Diabetes Care"},{"issue":"12","key":"2026090305475653100_luag216-B18","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1210\/jc.2007-0918","article-title":"Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal","volume":"92","author":"Goldfine","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026090305475653100_luag216-B19","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/dme.13443","article-title":"Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass","volume":"34","author":"Svane","year":"2017","journal-title":"Diabet Med"},{"issue":"9","key":"2026090305475653100_luag216-B20","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2337\/db16-0341","article-title":"Gastric bypass reduces symptoms and hormonal responses in hypoglycemia","volume":"65","author":"Abrahamsson","year":"2016","journal-title":"Diabetes"},{"issue":"7","key":"2026090305475653100_luag216-B21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2026090305475653100_luag216-B22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1210\/jc.2008-2152","article-title":"Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes","volume":"94","author":"Ahr\u00e9n","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026090305475653100_luag216-B23","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/db11-0979","article-title":"Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans","volume":"60","author":"Christensen","year":"2011","journal-title":"Diabetes"},{"issue":"4","key":"2026090305475653100_luag216-B24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248560","article-title":"Interpreting blood GLUcose data with R package iglu","volume":"16","author":"Broll","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"2026090305475653100_luag216-B25","doi-asserted-by":"crossref","first-page":"e3235","DOI":"10.1210\/clinem\/dgab103","article-title":"PREVENT: a randomized, placebo-controlled crossover trial of avexitide for treatment of postbariatric hypoglycemia","volume":"106","author":"Craig","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/10\/luag216\/70937402\/luag216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/10\/luag216\/70937402\/luag216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:48:13Z","timestamp":1788428893000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag216\/8780967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag216","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,3]]},"article-number":"luag216"}}